BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26120471)

  • 1. Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR.
    Mangolini A; Ferracin M; Zanzi MV; Saccenti E; Ebnaof SO; Poma VV; Sanz JM; Passaro A; Pedriali M; Frassoldati A; Querzoli P; Sabbioni S; Carcoforo P; Hollingsworth A; Negrini M
    Biomark Res; 2015; 3():12. PubMed ID: 26120471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison between quantitative PCR and droplet digital PCR technologies for circulating microRNA quantification in human lung cancer.
    Campomenosi P; Gini E; Noonan DM; Poli A; D'Antona P; Rotolo N; Dominioni L; Imperatori A
    BMC Biotechnol; 2016 Aug; 16(1):60. PubMed ID: 27538962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absolute quantification of cell-free microRNAs in cancer patients.
    Ferracin M; Lupini L; Salamon I; Saccenti E; Zanzi MV; Rocchi A; Da Ros L; Zagatti B; Musa G; Bassi C; Mangolini A; Cavallesco G; Frassoldati A; Volpato S; Carcoforo P; Hollingsworth AB; Negrini M
    Oncotarget; 2015 Jun; 6(16):14545-55. PubMed ID: 26036630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Significance of Circulating miR-1273g-3p and miR-122-5p in Pancreatic Cancer.
    Mazza T; Gioffreda D; Fontana A; Biagini T; Carella M; Palumbo O; Maiello E; Bazzocchi F; Andriulli A; Tavano F
    Front Oncol; 2020; 10():44. PubMed ID: 32117716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma.
    Moshiri F; Salvi A; Gramantieri L; Sangiovanni A; Guerriero P; De Petro G; Bassi C; Lupini L; Sattari A; Cheung D; Veneziano D; Nigita G; Shankaraiah RC; Portolani N; Carcoforo P; Fornari F; Bolondi L; Frassoldati A; Sabbioni S; Colombo M; Croce CM; Negrini M
    Oncotarget; 2018 Mar; 9(20):15350-15364. PubMed ID: 29632649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
    Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
    Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Droplet digital PCR-based circulating microRNA detection serve as a promising diagnostic method for gastric cancer.
    Zhao G; Jiang T; Liu Y; Huai G; Lan C; Li G; Jia G; Wang K; Yang M
    BMC Cancer; 2018 Jun; 18(1):676. PubMed ID: 29929476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
    Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of reference miRNAs in plasma useful for the study of oestrogen-responsive miRNAs associated with acquired Protein S deficiency in pregnancy.
    Tay JW; James I; Hughes QW; Tiao JY; Baker RI
    BMC Res Notes; 2017 Jul; 10(1):312. PubMed ID: 28743297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence.
    Sueta A; Yamamoto Y; Tomiguchi M; Takeshita T; Yamamoto-Ibusuki M; Iwase H
    Oncotarget; 2017 Sep; 8(41):69934-69944. PubMed ID: 29050253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNAs in Sera of Tunisian patients discriminate between inflammatory breast cancer and non-inflammatory breast cancer.
    Hamdi K; Goerlitz D; Stambouli N; Islam M; Baroudi O; Neili B; Benayed F; Chivi S; Loffredo C; Jillson IA; Benammar Elgaaied A; Blancato JK; Marrakchi R
    Springerplus; 2014; 3():636. PubMed ID: 26034677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five serum-based miRNAs were identified as potential diagnostic biomarkers in gastric cardia adenocarcinoma.
    Wang J; Zhang H; Zhou X; Wang T; Zhang J; Zhu W; Zhu H; Cheng W
    Cancer Biomark; 2018; 23(2):193-203. PubMed ID: 30198863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasma.
    Bowden M; Zhou CW; Zhang S; Brais L; Rossi A; Naudin L; Thiagalingam A; Sicinska E; Kulke MH
    Oncotarget; 2017 Aug; 8(33):54331-54344. PubMed ID: 28903345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating MiR-19b-3p, MiR-134-5p and MiR-186-5p are Promising Novel Biomarkers for Early Diagnosis of Acute Myocardial Infarction.
    Wang KJ; Zhao X; Liu YZ; Zeng QT; Mao XB; Li SN; Zhang M; Jiang C; Zhou Y; Qian C; Feng KG; Guan HQ; Tang TT; Cheng X; Chen ZJ
    Cell Physiol Biochem; 2016; 38(3):1015-29. PubMed ID: 26939053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulated circulating microRNAs after surgery: potential noninvasive biomarkers for diagnosis and prognosis of early breast cancer.
    Wang Y; Yin W; Lin Y; Yin K; Zhou L; Du Y; Yan T; Lu J
    Cell Death Discov; 2018; 4():21. PubMed ID: 30109140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Droplet digital PCR as a novel detection method for quantifying microRNAs in acute myocardial infarction.
    Robinson S; Follo M; Haenel D; Mauler M; Stallmann D; Tewari M; Duerschmied D; Peter K; Bode C; Ahrens I; Hortmann M
    Int J Cardiol; 2018 Apr; 257():247-254. PubMed ID: 29506703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
    Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.
    Li HY; Liang JL; Kuo YL; Lee HH; Calkins MJ; Chang HT; Lin FC; Chen YC; Hsu TI; Hsiao M; Ger LP; Lu PJ
    Breast Cancer Res; 2017 Dec; 19(1):133. PubMed ID: 29258605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of a Subset of Circulating and Vesicle-Associated miRNA in Pancreatic Cancer.
    Girolimetti G; Pelisenco IA; Eusebi LH; Ricci C; Cavina B; Kurelac I; Verri T; Calcagnile M; Alifano P; Salvi A; Bucci C; Guerra F
    Noncoding RNA; 2024 May; 10(3):. PubMed ID: 38804361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.